Tenascin-X gene defects and cardiovascular disease

Med Hypotheses. 2014 Dec;83(6):844. doi: 10.1016/j.mehy.2014.01.027. Epub 2014 Mar 22.

Authors

Rachel Morissette¹, Nazli B McDonnell², Deborah P Merke³

Affiliations

¹ The National Institutes of Health, Clinical Center, Bethesda, MD, USA.
² The National Institutes of Health, National Institute on Aging, Baltimore, MD, USA.
³ The National Institutes of Health, Clinical Center, Building 10, CRC, Room 1-2740, 10 Center Drive, MSC 1932, Bethesda, MD 20892-1932, USA; The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA. Electronic address: dmerke@nih.gov.

PMID: 24709065
DOI: 10.1016/j.mehy.2014.01.027

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural
Comment

MeSH terms

Cardiovascular Diseases / prevention & control*
Ehlers-Danlos Syndrome / genetics*
Ehlers-Danlos Syndrome / pathology*
Humans
Tenascin / deficiency*
Tenascin / metabolism*

Substances

Tenascin

Grants and funding

Intramural NIH HHS/United States